Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OctaHeal BioCell Collagen
- Development stage
- Unknown
- Lead developer
- Faran Shimi
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Administration
- Oral
01
Overview
OctaHeal BioCell Collagen is an oral dietary supplement developed and manufactured by Faran Shimi. It contains BioCell Collagen, a patented, clinically tested ingredient derived from chicken sternal cartilage. BioCell Collagen consists of a naturally occurring matrix of hydrolyzed collagen type II (60%), chondroitin sulfate (20%), and hyaluronic acid (10%). This highly bioavailable matrix is designed to support joint health, reduce joint pain and inflammation, improve joint mobility, and promote skin health by enhancing hydration and reducing wrinkles. The supplement is formulated as 500 mg capsules for oral administration.
- Brand names
- OctaHeal BioCell Collagen
- Other names
- BioCell Collagen
Beyond the preview
Go deeper on OctaHeal BioCell Collagen.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OctaHeal BioCell Collagen.